Louise is Director of the
Pre-eclampsia is a very common condition affecting 5% of first time mothers. Currently, 70-80,000 mothers and over 500,000 infant deaths are attributed to pre-eclampsia each year and it is responsible for occupancy of approximately 20% of neonatal intensive care unit cots. If 'at risk' first time mothers could be identified in early pregnancy, steps could be taken to prevent almost a third of cases.
Professor Kenny received the award at the Enterprise Ireland Big Ideas Technology Showcase which took place in
Presenting Professor Kenny with her award, Sean Sherlock T.D Minister for Research & Innovation said; "Professor Kenny has accomplished a huge amount in her career to date so it is very fitting that this award from Enterprise Ireland recognises her contribution to society and the economy. Through the commercialisation of this technology Louise and her team will help women and their babies, deliver cost savings to hospitals and create employment".
"Over the course of her career Professor Kenny could see the problems caused by being unable to predict which women would develop pre-eclampsia in pregnancy. So she decided to do something about it and using public funding provided by Science Foundation Ireland and the Health Research Board, she and her research team developed the world's first predictive diagnostic blood test for pre-eclampsia".
"With the help of Enterprise Ireland the test was put through a technical evaluation and brought to the point where it was 'investor ready'. Enterprise
Congratulating his colleague on her award,
Minister Sherlock also presented Enterprise Ireland Commercialisation Awards to
About the Enterprise Ireland Big Ideas Technology Showcase:
The inventors, the majority of whom started out as academic researchers, were given an opportunity to outline their technology offer at what has become an annual fixture in the Irish venture capital and investment sector's diary.
Amongst the technologies on offer were;
* Smart paint that can transform any surface into a whiteboard;
* A number of ICT technologies;
* Innovative treatments for medical conditions like high-blood pressure, varicose veins and deep-vein thrombosis;
* Clean up solutions for toxic sites using natural, low-cost technologies;
* Drug discovery technology;
* Non-stick, biodegradable chewing gum;
* of one-to-one commercial discussions between the inventors and potential investors took place after the pitches.
The inventors produced short pitches and are available on YouTube https://www.youtube.com/playlist?list=PLVq7KwtasXcCWTthGh0kA13q_hiiySnkm
All the technologies were built on publicly-funded research conducted in
CC AutoTriage1pm-130928-30TagarumaMar-4503588 30TagarumaMar
Most Popular Stories
- American Airlines, US Airways Complete Merger
- ACA Delay Stresses Small Businesses
- Questions Remain in Jenni Rivera's Death
- Unemployed Wait as Lawmakers Debate
- Harley Issues Motorcycle Recall
- General Dynamics Plans 200 New Jobs in N.M.
- Auto Dealer Builds Big Solar Project
- Entrepreneurs' Next Creation May Be New Laws
- Saab Gets Back into the Game; U.S. Auto Sales Soar
- Dell Offers Undisclosed Number of Employee Buyouts